Development of a population pharmacokinetic model to describe azithromycin whole-blood and plasma concentrations over time in healthy subjects.

Pene Dumitrescu, T

Development of a population pharmacokinetic model to describe azithromycin whole-blood and plasma concentrations over time in healthy subjects. [electronic resource] - Antimicrobial agents and chemotherapy Jul 2013 - 3194-201 p. digital

Publication Type: Clinical Trial; Journal Article

1098-6596

10.1128/AAC.02430-12 doi


Administration, Oral
Adult
Anti-Bacterial Agents--blood
Azithromycin--blood
Half-Life
Humans
Leukocytes, Mononuclear--drug effects
Male
Middle Aged
Neutrophils--drug effects
Plasma
Young Adult